4078 — Sakai Chemical Industry Co Balance Sheet
0.000.00%
- ¥45bn
- ¥52bn
- ¥84bn
- 77
- 92
- 84
- 98
Annual balance sheet for Sakai Chemical Industry Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 11,093 | 10,800 | 12,409 | 16,590 | 16,183 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 27,129 | 29,868 | 27,519 | 29,542 | 26,977 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 60,260 | 65,496 | 72,101 | 76,042 | 71,416 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 48,621 | 48,134 | 46,761 | 40,463 | 44,520 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 123,007 | 123,919 | 128,021 | 125,445 | 123,319 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 26,178 | 26,771 | 29,237 | 31,757 | 27,910 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 47,202 | 45,065 | 47,533 | 51,053 | 45,028 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 75,805 | 78,854 | 80,488 | 74,392 | 78,291 |
| Total Liabilities & Shareholders' Equity | 123,007 | 123,919 | 128,021 | 125,445 | 123,319 |
| Total Common Shares Outstanding |